PTH and Hypercalcemia: The work of Sprague et al. (2003) in the United States demonstrated that paricalcitol is more effective over PTH levels in SHPT patients, achieving a reduction of iPTH levels over 50 % after 18 weeks of treatment with less sustained hypercalcemia [29].